Nutraceutix Licenses Subsidiary Of Boehringer-ingelheim To Market Calcium D-glucarate

Nutraceutix, Inc. has licensed , a subsidiary of Boehringer-Ingelheim, (Canada) Ltd. the non-exclusive right to distribute health supplement products containing the patented dietary supplement compound, Calcium D-Glucarate(TM). group, is one of the world’s 20 leading pharmaceutical corporations — with products focused on human pharmaceuticals (prescription, hospital and self-medication) as well as animal health.

, based in Burlington, Ontario, Canada, markets and distributes sports, diet, herbal and specialized nutraceutical products to health food stores in America and internationally, and collaborates with universities in allergy and cancer research.

Found naturally in fruits and vegetables, D-Glucarate(TM) may enhance the body’s capacity to resist many types of carcinogens and toxins.

According to Thomas J. Slaga, Ph.D., Director of Cancer Cause and Prevention at the AMC Cancer Center in Denver, Colorado, “There is strong scientific evidence that D-Glucarate(TM) prevents chemically induced cancers.”

joins Olympian Labs, Advanced Physicians Products, Country Life Vitamins, Highland Laboratories, Primary Source LLC, Pure Encapsulations, BioSynergy Nutraceuticals and others in adding the D-Glucarate(TM) technology to their product lines.

Nutraceutix, Inc. develops, licenses and manufactures proprietary and non-proprietary private-label health supplements and related products for major health supplement companies, with distribution to health food retailers, multilevels, and mass merchants.